Cozad Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,448
Closed -$209K 426
2025
Q4
$209K Buy
+2,448
New +$201K 0.02% 409
2024
Q3
Sell
-2,616
Closed -$242K 410
2024
Q2
$242K Hold
2,616
0.02% 351
2024
Q1
$250K Buy
+2,616
New +$220K 0.03% 349
2023
Q3
Sell
-2,616
Closed -$247K 386
2023
Q2
$247K Hold
2,616
0.03% 338
2023
Q1
$216K Buy
+2,616
New +$206K 0.03% 345
2022
Q4
Sell
-2,616
Closed -$216K 378
2022
Q3
$216K Sell
2,616
-300
-10% -$28.9K 0.04% 323
2022
Q2
$277K Sell
2,916
-435
-13% -$45K 0.04% 295
2022
Q1
$394K Sell
3,351
-3,122
-48% -$350K 0.06% 257
2021
Q4
$839K Sell
6,473
-1,034
-14% -$121K 0.12% 172
2021
Q3
$850K Sell
7,507
-10,239
-58% -$1.17M 0.13% 167
2021
Q2
$1.84M Sell
17,746
-16,495
-48% -$1.55M 0.29% 92
2021
Q1
$2.86M Sell
34,241
-10
-0% -$845 0.47% 56
2020
Q4
$3.13M Sell
34,251
-940
-3% -$78K 0.56% 46
2020
Q3
$2.81M Sell
35,191
-3,015
-8% -$235K 0.53% 51
2020
Q2
$2.64M Sell
38,206
-2,705
-7% -$192K 0.54% 51
2020
Q1
$2.57M Buy
40,911
+2,001
+5% +$144K 0.89% 31
2019
Q4
$3.03M Buy
38,910
+7,050
+22% +$551K 0.81% 32
2019
Q3
$2.33M Buy
+31,860
New +$2.24M 0.67% 45

Other funds holding EW

Cozad Asset Management's EW Position: Q1 2026 in Review

Cozad Asset Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 2,448 shares — an estimated $209K sold.

Cozad Asset Management first reported a position in EW in Q3 2019 and held it in 18 quarters. The position peaked at $3.13M in Q4 2020. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Cozad Asset Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Cozad Asset Management sold 2,448 Edwards Lifesciences shares in Q1 2026, an estimated $209K.
  • Cozad Asset Management first reported a position in Edwards Lifesciences in Q3 2019 and held it in 18 quarters.
  • Cozad Asset Management's Edwards Lifesciences position peaked at $3.13M in Q4 2020.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.